Autoimmune hemolytic anemias, Evans' syndromes, and pure red cell aplasia in non-Hodgkin lymphomas.
We analyzed 108 cases of non-CLL non-Hodgkin lymphoma (NHL) associated with autoimmune hemolytic anemia (AIHA) (+/- pure red cell aplasia (PRCA)) or Evans' syndrome. The analysis was based on cases reported in the literature, which were retrieved by means of Pubmed and Medline searches and of an original series of 121 patients with NHL as well as reference lists of papers in the field. The number of cases in various NHL subtypes was small (n = 6-25). Nevertheless, interesting and sometimes unexpected differences in sex prevalence, temporal relationship between onset of lymphoma and AIHA, stage of lymphoma, relative frequency of warm antibody-AIHA (WA-AIHA) and cold antibody (CA-AIHA), association with PRCA and response of AIHA to treatments were noted for various lymphoma entities. WA-AIHA was more frequent in B-cell lymphomas, while CA-AIHA and PRCA predominantly occurred in T-cell lymphomas. Anti-lymphoma treatment seemed to be more effective against AIHA than conventional therapy with steroids or immunoglobulin. Although generated by a literature survey, this compilation of data indicates a complex relation of lymphoma and AIHA and warrants more attention and specific studies.
Hauswirth
Alexander W
AW
Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Austria. alexander.hauswirth@meduniwien.ac.at
Skrabs
Cathrin
C
Schützinger
Christian
C
Gaiger
Alexander
A
Lechner
Klaus
K
Jäger
Ulrich
U
D000744:Anemia, Hemolytic, Autoimmune / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D006801:Humans; D007943:Leukemia, Hairy Cell / Q000150:complications; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications; D016393:Lymphoma, B-Cell / Q000150:complications; D008224:Lymphoma, Follicular / Q000150:complications; D020522:Lymphoma, Mantle-Cell / Q000150:complications; D008228:Lymphoma, Non-Hodgkin / Q000150:complications*; D016411:Lymphoma, T-Cell, Peripheral / Q000150:complications; D009101:Multiple Myeloma / Q000150:complications; D011379:Prognosis; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000209:etiology*; D012010:Red-Cell Aplasia, Pure / Q000209:etiology*; D012307:Risk Factors; D013577:Syndrome